Merck Judge Refuses Class-Action Status for Vioxx

Nov. 22 (Bloomberg) — Merck & Co. won a bid to block users of its Vioxx painkiller who claim the drug contributed to heart attacks and strokes from suing as a group. U.S. District Judge Eldon Fallon of New Orleans refused to grant class-action status to Vioxx users throughout the country who claim personal injury and wrongful death as a result of taking the drug, which was pulled from the market in 2004. Fallon ruled that the differences among the individual claims were too great to permit them to be tried together. For more information, please follow the link below.

Read More About Merck Judge Refuses Class-Action Status for Vioxx…